Ralph and Luci Schey Chair, and director, Schey Center for Cognitive Neuroimaging, Cleveland Clinic
Monitoring Progression in Multiple Sclerosis: Stephen Rao, PhD, ABPP-Cn
The Ralph and Luci Schey Chair and Director of the Schey Center for Cognitive Neuroimaging at Cleveland Clinic discussed his investigations into improving the MSPT.
Correcting Practice Effects on the MSPT: Stephen Rao, PhD, ABPP-Cn
The Ralph and Luci Schey Chair and Director of the Schey Center for Cognitive Neuroimaging at Cleveland Clinic discussed the importance of correcting practice effects to determine performance.
Factors That Influence Practice Effects: Stephen Rao, PhD, ABPP-Cn
The Ralph and Luci Schey Chair and Director of the Schey Center for Cognitive Neuroimaging at Cleveland Clinic discussed populations that exhibit greater practice effects than others.
The Issue of Practice Effects on MS Performance Tests: Stephen Rao, PhD, ABPP-Cn
The Ralph and Luci Schey Chair and Director of the Schey Center for Cognitive Neuroimaging at Cleveland Clinic discussed his team’s investigations presented at the 2021 AAN Annual Meeting.
Multiple Sclerosis Performance Test Battery: Stephen Rao, PhD, ABPP-Cn
The Ralph and Luci Schey Chair and Director of the Schey Center for Cognitive Neuroimaging at Cleveland Clinic, outlined the different tests that make up the MSPT battery.
Next Steps in Understanding Role of Exercise in Alzheimer Risk: Stephen Rao, PhD
The director of the Schey Center for Cognitive Neuroimaging at Cleveland Clinic shared the next steps in building on previous research that links exercise with a reduced Alzheimer disease risk.
Assessing High-Intensity Exercise to Prevent Alzheimer Disease: Stephen Rao, PhD; Jay Alberts, PhD
A duo of researchers from Cleveland Clinic outlined their new 5-year study that tests home-based intervention in high-risk individuals for Alzheimer disease.
